Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
PHASE2
Pre-clinical data and recently published clinical data suggest a synergisti...
Status
Completed
Location
University of Pennsylvania; Abramson Cancer Center; Lymphoma Program
Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy
PHASE3
This protocol is designed to compare the effect on bone of Zoledronic Acid ...
Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
PHASE2
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...